News
Stockhead on MSN1h
Neurizon inks global licensing deal with NYSE-listed ElancoNeurizon Therapeutics has inked an exclusive global licensing deal with New York Stock Exchange-listed Elanco Animal Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback